Position
Chief Legal Officer
Company
Avalo Therapeutics
Description
Avalo Therapeutics, Inc. announced the appointment of Paul Varki as its Chief Legal Officer. Paul brings over 20 years of experience in the pharmaceutical and biotech industry, and the company expects his appointment to enhance its strategic and legal competencies.
Quick answer
Avalo Therapeutics Appoints Paul Varki as Chief Legal Officer (June 24, 2024). Avalo Therapeutics is based in Rockville, Maryland, United States.
- Who is the new Chief Legal Officer at Avalo Therapeutics?
- Avalo Therapeutics named Paul Varki Chief Legal Officer, announced June 24, 2024.
- What did Avalo Therapeutics announce on June 24, 2024?
- Avalo Therapeutics, Inc. announced the appointment of Paul Varki as its Chief Legal Officer. Paul brings over 20 years of experience in the pharmaceutical and biotech industry, and the company expects his appointment to enhance its strategic and legal competencies.
- What does Avalo Therapeutics do?
- Avalo Therapeutics is a leading clinical-stage biopharmaceutical company that employs a precision medicine approach to discover, develop, and commercialize targeted therapeutics for patients with significant unmet...
- Where is Avalo Therapeutics based?
- Avalo Therapeutics is based in Rockville, Maryland, United States.
- Which similar companies made leadership changes around the same time?
- Arvinas (June 24, 2024), MaaT Pharma (June 24, 2024), MBX Biosciences, Inc. (June 25, 2024) and Actym Therapeutics (June 25, 2024) also announced leadership changes within 45 days of Avalo Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Arvinas Appoints Andrew Saik as Chief Financial Officer and Treasurer (June 24, 2024)
- MaaT Pharma Appoints Gianfranco Pittari, M.D., Ph.D., as Chief Medical Officer (June 24, 2024)
- MBX Biosciences Appoints Salomon (Sam) Azoulay, M.D, as Chief Medical Officer (June 25, 2024)
- Actym Therapeutics Appoints Mary J. Janatpour as Chief Scientific Officer and Shouryadeep Srivastava as Senior Vice President of Clinical Development (June 25, 2024)
- Immunome Appoints Phil Tsai, PhD, as Chief Technical Officer (June 27, 2024)
- Gain Therapeutics, Inc. Appoints Gene Mack as Interim CEO (June 27, 2024)
Who to call at Avalo Therapeutics, and when
A new leader at Avalo Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Avalo Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Avalo Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Avalo Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Avalo Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Avalo Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.